Leaderboard

En | De
No articles selected!     View Cart  
You are here: Psychiatry » Schizophrenia and Psychotic Disorders 23. December 2024
Search
medline.ch
Schizophrenia and Psychotic Disorders
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Anxiety Disorders
Dementia
Depressive Disorders
Eating Disorders
Personality Disorders
Schizophrenia and Psychotic Disorders
Sleep Disorders
Sexual Disorders
Somatoform Disorders
Substance-Related Disorders
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 3235  Previews Next
   
   Articles 1 - 20 / 64691  
   
Efficacy and safety of evenamide, a glutamate modulator, added to a second-generation antipsychotic in inadequately/poorly responding patients with chronic schizophrenia: results from a randomized, double-blind, placebo-controlled, phase 3, international clinical trial.
Neuropharmacology
Anand R, Turolla A, Chinellato G, Sansi F, Roy A, Hartman R.
PMID: 39708914 [PubMed - as supplied by publisher]


Associations between momentary mental states and concurrent social functioning after remission from first episode psychosis: A HAMLETT ecological momentary assessment study.
J Psychiatr Res
Djordjevic M, Jongsma HE, Simons CJP, Oomen PP, de Haan L, Boonstra N, Kikkert M, Koops S, Geraets CNW, Begemann MJH, HAMLETT-OPHELIA Consortium, Marcelis M, Veling W.
PMID: 39708772 [PubMed - as supplied by publisher]


Correction: Longitudinal change in neurocognitive functioning in children and adolescents at clinical high risk for psychosis: a systematic review.
Eur Child Adolesc Psychiatry
Pedruzo B, Aymerich C, Pacho M, Herrero J, Laborda M, Bordenave M, Giuliano AJ, McCutcheon RA, Gutiérrez-Rojas L, McGuire P, Stone WS, Fusar-Poli P, González-Torres MÁ, Catalan A.
PMID: 39708114 [PubMed - as supplied by publisher]


Characterizing the Clinical Trajectory and Predicting Persistence and Deterioration of Attenuated Psychotic Symptoms in Ultra-High-Risk Individuals.
Schizophr Bull
Wannan C, Scott I, Dwyer D, Clark SR, Hartmann S, Ye RR, Amminger GP, Yuen HP, Lavoie S, Markulev C, Schaefer MR, Hartmann JA, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger G, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Kerr M, Spark J, Wallis N, Polari A, McGorry PD, Nelson B.
PMID: 39707153 [PubMed - as supplied by publisher]


Investigation of choroid plexus variability in schizophrenia-spectrum disorders-insights from a multimodal study.
Schizophrenia (Heidelb)
Yakimov V, Moussiopoulou J, Roell L, Kallweit MS, Boudriot E, Mortazavi M, Papiol S, Kr, Campana M, Schulte EC, Glaichenhaus N, Martinuzzi E, Halstead S, Warren N, Siskind D, Maurus I, Hasan A, Falkai P, Schmitt A, Raabe FJ, CDP Working Group, Keeser D, Wagner E.
PMID: 39706851 [PubMed]


The factors associated with clozapine polypharmacy for schizophrenia patients discharged from a large public psychiatric hospital in Taiwan, 2006-2021.
Medicine (Baltimore)
Shih YJ, Lin CH, Chou LS.
PMID: 39705447 [PubMed - indexed for MEDLINE]


Effect of comprehensive intervention model based on drug-psychology-society-skills on medication compliance and cognitive ability of chronic schizophrenia patients.
World J Psychiatry
Wang HJ, Chen W, Yan XL, Huang QY, Xu WD.
PMID: 39704380 [PubMed]


Indigenous-non-Indigenous disparities in health and social outcomes 5 years after first episode psychosis: national cohort study.
BJPsych Open
Cunningham R, Petrovi, Gibb S, Crowe M, Manuel J, Pitama S, Crengle S, Porter R, Lacey C.
PMID: 39704316 [PubMed]


Prevalence and Factors Associated with Hypersalivation in Schizophrenia Inpatients Treated with Clozapine: A Retrospective Study.
Hosp Pharm
Kitsinthopchai C, Kumpeera S, Sangngarm A, Boonlue T.
PMID: 39703771 [PubMed - as supplied by publisher]


Protective role of school climate for impacts of COVID-19 on depressive symptoms and psychotic experiences among adolescents: a population-based cohort study.
Psychol Med
Yamaguchi S, DeVylder J, Yamasaki S, Ando S, Miyashita M, Hosozawa M, Baba K, Niimura J, Nakajima N, Usami S, Kasai K, Hiraiwa-Hasegawa M, Nishida A.
PMID: 39702993 [PubMed - as supplied by publisher]


Effects of mindfulness-based intervention in preventing relapse in patients with remitted psychosis: a randomized controlled trial.
Schizophrenia (Heidelb)
Hui CLM, Wong CCL, Lui ECY, Chiu TC, Tao TJ, Chan EWT, Lin J, Tong ACY, Suen YN, Chan CWH, Yeung WS, Lee EHM, Chan SKW, Chang WC, Chen EYH.
PMID: 39702769 [PubMed]


Addressing brain metabolic connectivity in treatment-resistant schizophrenia: a novel graph theory-driven application of (18)F-FDG-PET with antipsychotic dose correction.
Schizophrenia (Heidelb)
De Simone G, Iasevoli F, Barone A, Gaudieri V, Cuocolo A, Ciccarelli M, Pappatŕ S, de Bartolomeis A.
PMID: 39702476 [PubMed]


Cultural Beliefs About the Etiology of Schizophrenia and Expressed Emotion in Mexican Families.
Rev Colomb Psiquiatr (Engl Ed)
Audiffred-Jaramillo RI, Alba-García JEG.
PMID: 39701641 [PubMed - indexed for MEDLINE]


Effectiveness of Paliperidone Palmitate on Treatment Adherence and Relapse in the Adult Schizophrenia Population: A One-Year Mirror-Image Study in a Colombian Mental Health Care Facility.
Rev Colomb Psiquiatr (Engl Ed)
Ribero O, Castilloux AM, Agudelo LM, Machnicki G, Morales V, Perocco S, Castillon G, Moride Y.
PMID: 39701640 [PubMed - indexed for MEDLINE]


Immune-based Machine learning Prediction of Diagnosis and Illness State in schizophrenia and bipolar Disorder: How data bias and overfitting were avoided.
Brain Behav Immun
Skorobogatov K, Meysman P, Morrens M, Leboyer M, Picker L.
PMID: 39701331 [PubMed - as supplied by publisher]


Consistent frontal-limbic-occipital connections in distinguishing treatment-resistant and non-treatment-resistant schizophrenia.
Neuroimage Clin
Zhang Y, Gao S, Liang C, Bustillo J, Kochunov P, Turner JA, Calhoun VD, Wu L, Fu Z, Jiang R, Zhang D, Jiang J, Wu F, Peng T, Xu X, Qi S.
PMID: 39700898 [PubMed - as supplied by publisher]


Sex difference in alexithymia and cognitive impairment in chronic schizophrenia: a large sample study based on Chinese Han population.
Eur Arch Psychiatry Clin Neurosci
Yang K, Zhong Y, Yuan J, Xie Y, Tang H, Zhang XY.
PMID: 39699669 [PubMed - as supplied by publisher]


[Long-term courses in schizophrenia : A review of current results and developments].
Nervenarzt
Nenadi, Falkenberg I, Mehl S, Kircher T.
PMID: 39699660 [PubMed - as supplied by publisher]


Association of NOTCH4 and CYP2E1 Genetic Variants With Schizophrenia in the Bangladeshi Population: A Case-Control Study.
Health Sci Rep
Millat MS, Roy J, Rahman MA, Aziz MA, Islam S, Chowdhury MMI, Barek MA, Hussain MS, Uddin MS, Siddiqui SA, Islam MS.
PMID: 39698532 [PubMed]


Metabolic effects and clinical outcomes of olanzapine in schizophrenia: A systematic review and meta-analysis.
Heliyon
Jin W, Chen S, Li D, Chen Q, Zhu M, Wang M, Fu X, Lin P.
PMID: 39698079 [PubMed]


   
   Articles 1 - 20 / 64691    Page 1 of 3235  Previews Next

 
Rect Bottom
Adserver Footer
 

Username

Password

 

 

Forgot your username or password?

 

New User? Sign Up

Register to My Medline!

 

Learn more about the My Medline experience

more >>

  Time frame  
   

Sky right 1